CoChat

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges

Open access
O'Bryant, Sid E., Lista, Simone, Rissman, Robert A., Edwards, Melissa, Zhang, Fan, Hall, James, Zetterberg, Henrik, Lovestone, Simon, Gupta, Veer, Graff‐Radford, Neill, Martins, Ralph, Jeromin, Andreas, Waring, Stephen, Oh, Esther, Kling, Mitchel, Baker, Laura D., Hampel, Harald, ISTAART Blood Based Biomarker Professional Interest Area · 2016 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Cited by 63

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Introduction: This study investigated the comparability of potential Alzheimer's disease (AD) biomarkers across blood fractions and assay platforms. Methods: Nonfasting serum and plasma samples from 300 participants (150 AD patients and 150 controls) were analyzed. Proteomic markers were obtained via electrochemiluminescence or Luminex technology. Comparisons were conducted via Pearson correlations. The relative importance of proteins within an AD diagnostic profile was examined using random forest importance plots. Results: On the Meso Scale Discovery multiplex platform, 10 of the 21 markers shared >50% of the variance across blood fractions (serum amyloid A R 2 = 0.99, interleukin (IL)10 R 2 = 0.95, fatty acid‐binding protein (FABP) R 2 = 0.94, I309 R 2 = 0.94, IL‐5 R 2 = 0.94, IL‐6 R 2 = 0.94, eotaxin3 R 2 = 0.91, IL‐18 R 2 = 0.87, soluble tumor necrosis factor receptor 1 R 2 = 0.85, and pancreatic polypeptide R 2 = 0.81). When examining protein concentrations across platforms, only five markers shared >50% of the variance (beta 2 microglobulin R 2 = 0.92, IL‐18 R 2 = 0.80, factor VII R 2 = 0.78, CRP R 2 = 0.74, and FABP R 2 = 0.70). Discussion: The current findings highlight the importance of considering blood fractions and assay platforms when searching for AD relevant biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dadm.2015.12.003

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 63

Metadata

Authors
O'Bryant, S. E., Lista, S., Rissman, R. A., Edwards, M., Zhang, F., Hall, J., Zetterberg, H., Lovestone, S., Gupta, V., Graff‐Radford, N., Martins, R., Jeromin, A., Waring, S., Oh, E., Kling, M., Baker, L. D., Hampel, H., & Area, I. B. B. B. P. I.
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2015-12-29
Volume
3
Issue
1
Pages
27-34
ISSN
2352-8729 (ISSN-L)
OpenAlex
W2200373373
Cited by
63
References
8
FWCI
5.31
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. https://app.cochat.ai/papers/10.1016/j.dadm.2015.12.003
The paper
O'Bryant, S. E., Lista, S., Rissman, R. A., Edwards, M., Zhang, F., Hall, J., Zetterberg, H., Lovestone, S., Gupta, V., Graff‐Radford, N., Martins, R., Jeromin, A., Waring, S., Oh, E., Kling, M., Baker, L. D., Hampel, H., & Area, I. B. B. B. P. I. (2016). Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2015.12.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.